These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2496942)

  • 21. Presence of glycoproteins containing the polylactosamine structure in brain and liver of GM1 gangliosidosis patients. Comparative study between clinical types I and II, using endo-beta-galactosidase enzyme.
    Berra B; De Gasperi R; Rapelli S; Okada S; Li SC; Li YT
    Neurochem Pathol; 1986 Apr; 4(2):107-17. PubMed ID: 3088498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GM1 gangliosidosis: phenotypic variation in a single family.
    Farrell DF; Ochs U
    Ann Neurol; 1981 Mar; 9(3):225-31. PubMed ID: 6784662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incorporation and degradation of GM1 ganglioside and asialoGM1 ganglioside in cultured fibroblasts from normal individuals and patients with beta-galactosidase deficiency.
    Kobayashi T; Shinnoh N; Kuroiwa Y
    Biochim Biophys Acta; 1986 Jan; 875(1):115-21. PubMed ID: 3079639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morquio B syndrome: a primary defect in beta-galactosidase.
    van der Horst GT; Kleijer WJ; Hoogeveen AT; Huijmans JG; Blom W; van Diggelen OP
    Am J Med Genet; 1983 Oct; 16(2):261-75. PubMed ID: 6418007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lysosomal beta-galactosidase properties and the molecular genetics of GM1 gangliosidosis].
    Vel'tishchev IuE; Kalaidzhieva LV
    Vopr Med Khim; 1979; 25(6):709-15. PubMed ID: 117628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary oligosaccharide excretion and severity of galactosialidosis and sialidosis.
    Takahashi Y; Nakamura Y; Yamaguchi S; Orii T
    Clin Chim Acta; 1991 Dec; 203(2-3):199-210. PubMed ID: 1777981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type 3 (adult) GM1 gangliosidosis: case report.
    Ohta K; Tsuji S; Mizuno Y; Atsumi T; Yahagi T; Miyatake T
    Neurology; 1985 Oct; 35(10):1490-4. PubMed ID: 3929160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzyme replacement for GM1-gangliosidosis: Uptake, lysosomal activation, and cellular disease correction using a novel β-galactosidase:RTB lectin fusion.
    Condori J; Acosta W; Ayala J; Katta V; Flory A; Martin R; Radin J; Cramer CL; Radin DN
    Mol Genet Metab; 2016 Feb; 117(2):199-209. PubMed ID: 26766614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical course of GM1 gangliosidoses.
    Kohlschütter A
    Neuropediatrics; 1984 Sep; 15 Suppl():71-3. PubMed ID: 6443743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acid beta-galactosidase from human fibroblasts. A microscale purification method monitored by a highly sensitive enzyme assay.
    Furuya T; Suzuki Y; Momoi T
    J Biochem; 1986 Feb; 99(2):437-43. PubMed ID: 3084462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transient high-level expression of beta-galactosidase after transfection of fibroblasts from GM1 gangliosidosis patients with plasmid DNA.
    Balestrin RC; Baldo G; Vieira MB; Sano R; Coelho JC; Giugliani R; Matte U
    Braz J Med Biol Res; 2008 Apr; 41(4):283-8. PubMed ID: 18392450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Deficiency of GM1 ganglioside beta-galactosidase--GM1 gangliosidosis].
    Okada S
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):741-4. PubMed ID: 3152094
    [No Abstract]   [Full Text] [Related]  

  • 33. Type 2 GM1 gangliosidosis with long survival and neuronal ceroid lipofuscinosis.
    Lowden JA; Callahan JW; Gravel RA; Skomorowski MA; Becker L; Groves J
    Neurology; 1981 Jun; 31(6):719-24. PubMed ID: 6787458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a penta-and an octasaccharide from urine of a patient with juvenile GM1-gangliosidosis.
    Lunblad A; Sjöblad S; Svensson S
    Arch Biochem Biophys; 1978 May; 188(1):130-6. PubMed ID: 98112
    [No Abstract]   [Full Text] [Related]  

  • 35. [The metabolism of radiolabelled GM1-ganglioside in cultured skin fibroblasts from controls and patients with GM1-gangliosidosis].
    Inui K
    Nihon Rinsho; 1995 Dec; 53(12):3102-4. PubMed ID: 8577066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GM1 gangliosidosis (type 1) in a cat.
    Barker CG; Blakemore WF; Dell A; Palmer AC; Tiller PR; Winchester BG
    Biochem J; 1986 Apr; 235(1):151-8. PubMed ID: 3091002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic GM1 gangliosidosis presenting as dystonia: II. Biochemical studies.
    Kobayashi T; Suzuki K
    Ann Neurol; 1981 May; 9(5):476-83. PubMed ID: 6791575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GM1-ganglioside beta-galactosidase in leukocytes and cultured fibroblasts.
    Raghavan SA; Gajewski A; Kolodny EH
    Clin Chim Acta; 1977 Nov; 81(1):47-56. PubMed ID: 411612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A severe infantile sialidosis (beta-galactosidase-alpha-neuraminidase deficiency) mimicking GM1-gangliosidosis type 1.
    Okada S; Sugino H; Kato T; Yutaka T; Koike M; Dezawa T; Yamano T; Yabuuchi H
    Eur J Pediatr; 1983 Sep; 140(4):295-8. PubMed ID: 6414819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired degradation of keratan sulfate in GM1-gangliosidosis.
    Yutaka T; Okada S; Kato T; Yabuuchi H
    Clin Chim Acta; 1982 Oct; 125(2):233-40. PubMed ID: 6216030
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.